Publications by authors named "Greg R Bowman"

Mutations at a highly conserved homologous residue in three closely related muscle myosins cause three distinct diseases involving muscle defects: R671C in β-cardiac myosin causes hypertrophic cardiomyopathy, R672C and R672H in embryonic skeletal myosin cause Freeman-Sheldon syndrome, and R674Q in perinatal skeletal myosin causes trismus-pseudocamptodactyly syndrome. It is not known whether their effects at the molecular level are similar to one another or correlate with disease phenotype and severity. To this end, we investigated the effects of the homologous mutations on key factors of molecular power production using recombinantly expressed human β, embryonic, and perinatal myosin subfragment-1.

View Article and Find Full Text PDF
Article Synopsis
  • Individuals with severe herpesvirus infections often have issues with natural killer (NK) cells, and new research identifies genetic defects in PLCG2 as a cause of these immunodeficiencies.
  • The study focused on two families with NK-cell dysfunction using techniques like whole-exome sequencing and functional assays to discover novel loss-of-function variants in PLCG2.
  • Findings show that PLCG2 haploinsufficiency leads to impaired NK-cell activity while B-cell function remains normal, suggesting a new syndrome specifically associated with susceptibility to herpesvirus infections.
View Article and Find Full Text PDF

Mutations at a highly conserved homologous residue in three closely related muscle myosins cause three distinct diseases involving muscle defects: R671C in -cardiac myosin causes hypertrophic cardiomyopathy, R672C and R672H in embryonic skeletal myosin cause Freeman Sheldon syndrome, and R674Q in perinatal skeletal myosin causes trismus-pseudocamptodactyly syndrome. It is not known if their effects at the molecular level are similar to one another or correlate with disease phenotype and severity. To this end, we investigated the effects of the homologous mutations on key factors of molecular power production using recombinantly expressed human , embryonic, and perinatal myosin subfragment-1.

View Article and Find Full Text PDF